Second-Line Combination Chemotherapy with Docetaxel for Cisplatin-Pretreated Refractory Metastatic Esophageal Cancer: A Preliminary Report of Initial Experience - Concepedia

Concepedia

Publication | Closed Access

Second-Line Combination Chemotherapy with Docetaxel for Cisplatin-Pretreated Refractory Metastatic Esophageal Cancer: A Preliminary Report of Initial Experience

28

Citations

17

References

2007

Year

Toshiaki Tanaka, Hiromasa Fujita, Susumu Sueyoshi, Yuichi Tanaka, Hiroko Sasahara, Naoki Mori, Tsuyoshi Nagano, Hideaki Yamana, Kazuo Shirouzu

Abstract

DFC is a feasible and promising regimen as a second-line therapy in metastatic/recurrent esophageal cancer refractory to cisplatin-based chemotherapy.

References

	Year	Citations

Page 1